MYELODYSPLASTIC SYNDROME (MDS)
Clinical trials for MYELODYSPLASTIC SYNDROME (MDS) explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME (MDS) trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: drug added to transplant process
Disease control OngoingThis study is testing the safety of adding a drug called venetoclax to the standard treatment given before a bone marrow transplant for people with high-risk blood cancers like AML and MDS. It also tests giving venetoclax with other drugs after the transplant to try to prevent th…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists collect cancer samples to hunt for future cures
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and bone marrow samples from people with blood cancers like leukemia and lymphoma. Researchers will study these samples in the lab to better understand how these cancers work. The goal is to find new targets for future treatments and improve detection me…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC